These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3985727)

  • 1. Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal vein pressure.
    Rector WG
    Arch Intern Med; 1985 Apr; 145(4):648-50. PubMed ID: 3985727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
    Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
    Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol therapy for portal hypertension in children.
    Ozsoylu S; Koçak N; Yüce A
    J Pediatr; 1985 Feb; 106(2):317-21. PubMed ID: 3968624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.
    Hillon P; Blanchet L; Lebrec D
    Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of propranolol on portal venous pressure.
    Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
    Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
    Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
    Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
    Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
    Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis.
    Willett IR; Esler M; Jennings G; Dudley FJ
    Lancet; 1986 Oct; 2(8513):939-43. PubMed ID: 2877130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure.
    Boyer TD; Triger DR; Horisawa M; Redeker AG; Reynolds TB
    Gastroenterology; 1977 Apr; 72(4 Pt 1):584-9. PubMed ID: 838210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol--a medical treatment for portal hypertension?
    Lebrec D; Nouel O; Corbic M; Benhamou JP
    Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
    Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
    Hadengue A; Moreau R; Cerini R; Koshy A; Lee SS; Lebrec D
    Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
    Perelló A; Escorsell A; Bru C; Gilabert R; Moitinho E; García-Pagán JC; Bosch J
    Hepatology; 1999 Dec; 30(6):1393-7. PubMed ID: 10573517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.
    Sarin SK; Groszmann RJ; Mosca PG; Rojkind M; Stadecker MJ; Bhatnagar R; Reuben A; Dayal Y
    J Clin Invest; 1991 Mar; 87(3):1032-6. PubMed ID: 1900306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis.
    Keiding S; Solvig J; Grønbaek H; Vilstrup H
    Scand J Gastroenterol; 2004 Jun; 39(6):594-9. PubMed ID: 15223686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
    Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
    Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.
    Luca A; García-Pagán JC; Feu F; Lopez-Talavera JC; Fernández M; Bru C; Bosch J; Rodés J
    Hepatology; 1995 Jan; 21(1):83-8. PubMed ID: 7806173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.